3.5 mcg/mL Fentanyl Citrate and 0.0625%Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 125 mL in 150 mL Baxter Intravia Bag, Service Code 2K8470, Rx Only, Compounded by PharMEDium Services, LLC, Memphis, TN 36141, NDC 61553-470-30
Published July 27, 2016 · Recall initiated: May 5, 2016
Summary
FDA records drug Class II recall D-1417-2016, published July 27, 2016 and initiated May 5, 2016. Recalling firm: Pharmedium Services, LLC; Status: Terminated; Reported quantity: 1,015 bags; Lot: Lot Number 160390336M , Exp. Date 5/9/2016 ; Lot Number 160530318M , Exp. Date 5/23/2016 ; Lot Number 160600347M , Exp. Date 5/30/2016 ; Lot Number 160750243M , Exp. Date 6/14/2016 ; Lot Number 160760164M , Exp. Date 6/14/2016 ; Lot Number 160830228M , Exp. Date 6/22/2016 ; Lot Number 160890224M , Exp. Date 6/28/2016 ; Lot Number 160960242M , Exp. Date 7/5/2016 ; Lot Number 160970140M , Exp. Date 7/6/2016 . Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Pharmedium Services, LLC
- Distributor
- Nationwide
- Lot
- Lot Number 160390336M , Exp. Date 5/9/2016 ; Lot Number 160530318M , Exp. Date 5/23/2016 ; Lot Number 160600347M , Exp. Date 5/30/2016 ; Lot Number 160750243M , Exp. Date 6/14/2016 ; Lot Number 160760164M , Exp. Date 6/14/2016 ; Lot Number 160830228M , Exp. Date 6/22/2016 ; Lot Number 160890224M , Exp. Date 6/28/2016 ; Lot Number 160960242M , Exp. Date 7/5/2016 ; Lot Number 160970140M , Exp. Date 7/6/2016 ;
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDANORepinephrine Bitartrate 4 mg added to 250 mL 5% Dextrose Injection USP (16 mcg per mL) Total Volume 254.00January 1, 2020
- FDANORepinephrine Bitartrate 8 mg added to 250 mL 5% Dextrose Injection USP (32 mcg per mL) Total Volume 258.00January 1, 2020
- FDANORepinephrine Bitartrate 8 mg added to 500 mL 5% Dextrose Injection USP (16 mcg per mL) Total Volume 508.00January 1, 2020
- FDAFentanyl Citrate 2 mcg per mL (200 mcg per 100 mL) and Ropivacaine HCl 0.2% in Sodium Chloride 0.9%,December 26, 2018
- FDA3 mcg/mL Fentanyl Citrate and 0.125% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride; 100 mL inJuly 27, 2016
- FDA4 mcg/mL Fentanyl Citrate and 0.1% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride 50 mL in 60 mLJuly 27, 2016
Questions about this recall
Was 3.5 mcg/mL Fentanyl Citrate and 0.0625%Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 125 mL in 150 mL Baxter Intravia Bag, Service Code 2K8470, Rx Only, Compounded by PharMEDium Services, LLC, Memphis, TN 36141, NDC 61553-470-30 recalled?
Yes. FDA published recall D-1417-2016 on July 27, 2016. Reported hazard: Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail